Health Care & Life Sciences » Pharmaceuticals | Clearside Biomedical Inc.

Clearside Biomedical Inc.

Clearside Biomedical Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.52
Market Cap
$40.42 M
Shares Outstanding
37.6 M
Public Float
24.49 M

Profile

Address
900 North Point parkway
Alpharetta Georgia 30005
United States
Employees -
Website http://www.clearsidebio.com
Updated 07/08/2019
Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H.

Financials

View All

Daniel H. White
President, Chief Executive Officer & Director
William D. Humphries
Chairman